MassRobotics, FESTO, Mitsubishi Electric, Novanta and MITRE introduce the 2022 Healthcare Robotics Startup Catalyst Cohort, With Nearly Double the Participants from 2021 – Yahoo Finance

BOSTON, MA / ACCESSWIRE / November 22, 2022 / MassRobotics announces the participants in the Healthcare Robotics Startup Catalyst Cohort II. The selected companies are: Acumino.Robot on Rails, ABLE Human Motion, Andromeda Robotics, Unlimited Robotics, Maestro Surgical Robotics and Zeta Surgical. The Healthcare Robotics Startup Catalyst is designed and led by MassRobotics along with Festo, Mitsubishi Electric, Novanta and MITRE.

The program cohort for 2022

The MassRobotics Healthcare Robotics Startup Catalyst program advances healthcare robotics companies by providing the connections, guidance and resources they need to grow and succeed. Each startup is matched with an experienced executive mentor for a six-month period during which the pair works closely to address core needs to help the startup accelerate their scaling process. The Catalyst Program began in 2021, supporting four startups, mentored by MassRobotics and FESTO as an initiative to support healthcare initiatives during the pandemic.

“We are thrilled to see such a diverse and talented cohort of startups tackling healthcare robotics challenges be part of this program. They have a passion for improving people’s lives and they are not shying away from “tough tech.” The teams are global, with gender and racial representation. This is what we want to see more of in tech!,” said Nissia Sabri, VP of Engineering at Novanta.

“We are delighted to be able to mentor and assist the selected startups in accomplishing their milestones. We are grateful to Mitsubishi Electric, Novanta and MITRE for joining the committee. It is thanks to you all that we are now able to expand our program to support twice as many startups in Cohort 2. We wish all the selected startups much success and look forward to contributing towards reaching their goals,” said Nuzha Yakoob, Head of Technology & Innovation at FESTO.

The selected companies were chosen from worldwide applicants who sought the connections, guidance and resources they need to grow and succeed from the organizing companies and the greater healthcare robotics community. Applicants proposed solutions within the clinical care, public safety, laboratory and supply chain automation, out-of-hospital care, quality of life, and continuity of work and education, healthcare professionals’ training and support.

“We are proud of the support that the MassRobotics community provides to the healthcare industry in forwarding robotics innovation and entrepreneurship. The program rests on the partner organizations and has enthusiastically piqued interest from members of our Healthcare Robotics and Biotech Working Group, including hospitals, physicians, pharmaceutical companies, universities and other corporates,” said Juan Necochea, manager of strategic partnerships at MassRobotics.

ABLE human motion

“At ABLE we are very happy to be part of this year’s cohort and look forward to working hand in hand with our mentor Nuzha Yakoob, Head of Technology & Innovation at FESTO, and other key players of the robotics space, to enhance the impact of our groundbreaking exoskeleton solution at a global scale,” said Alfons Carnicero Carmona, Co-Founder and CEO.

“We are happy to receive worldwide startups’ applications and honored to mentor selected finalists to leverage the robot into healthcare and medical applications,” said William Nguyen, R&D Manager at Mitsubishi Electric Automation.

Unlimited Robotics’s Gary in hospital environment

The selected startups for Healthcare Robotics Startup Catalyst Cohort II are:

MassRobotics, Tuesday, November 22, 2022, Press release …….

Source: https://news.google.com/__i/rss/rd/articles/CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tYXNzcm9ib3RpY3MtZmVzdG8tbWl0c3ViaXNoaS1lbGVjdHJpYy1ub3ZhbnRhLTE2NTAwMDc0MS5odG1s0gFkaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvbWFzc3JvYm90aWNzLWZlc3RvLW1pdHN1YmlzaGktZWxlY3RyaWMtbm92YW50YS0xNjUwMDA3NDEuaHRtbA?oc=5

Leave a Reply

Your email address will not be published. Required fields are marked *